Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

15.77
BATS BZX Real-Time Price
As of 11:16am ET
 +0.13 / +0.83%
Today’s Change
7.65
Today|||52-Week Range
19.62
+18.48%
Year-to-Date
No recent news for Lexicon Pharmaceuticals Inc.

Today’s Trading

Previous close15.64
Today’s open14.49
Day’s range14.39 - 16.23
Volume25,747
Average volume (3 months)809,725
Market cap$1.6B
Dividend yield--
Data as of 11:16am ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)+96.24%
Earnings growth (this year)-2,962.23%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)+468.89%
P/E ratioNM
Price/Sales10.61
Price/Book5.67

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp-0.25-0.50%
TBPHTheravance Biopharma...-0.05-0.17%
PBYIPuma Biotechnology I...+0.15+0.36%
CLVSClovis Oncology Inc+0.50+1.34%
Data as of 11:16am ET, 12/06/2016

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$130.0M
Annual profit (last year)-$4.7M
Net profit margin-3.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts


Search for Jobs